[1] Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2):281-297. [2] Barroso-del Jesus A, Lucena-Aguilar G, Menendez P. The miR-302-367 cluster as a potential stemness regulator in ESCs[J]. Cell Cycle, 2009, 8(3):394-398. [3] Rosa A, Spagnoli FM, Brivanlou AH.The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection[J]. Dev Cell, 2009, 16(4):517-527. [4] Parchem RJ, Moore N, Fish JL, et al.miR-302 is required for timing of neural differentiation, neural tube glosure, and embryonic viability[J]. Cell Rep, 2015, 12(5):760-773. [5] Wade SL, Langer LF, Ward JM, et al.MiRNA-mediated regulation of the SWI/SNF chromatin remodeling complex controls pluripotency and endodermal differentiation in human ESCs[J]. Stem Cells, 2015, 33(10):2925-2935. [6] Lu Y, Loh YH, Li H, et al.Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells[J]. Cell Stem Cell, 2014, 15(1):92-101. [7] 王宏, 田海滨, 陈娟, 等. Knockout血清替代品可提高C57BL/6J小鼠胚胎干细胞建系效率[J]. 细胞与分子免疫学杂志, 2007, 23(3):269-276. [8] Lin SL, Chang DC, Chang-Lin S, et al.Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state[J]. RNA, 2008, 14(10):2115-2124. [9] Lin SL, Chang DC, Lin CH, et al.Regulation of somatic cell reprogramming through inducible mir-302 expression[J]. Nucleic Acids Res, 2011, 39(3):1054-1065. [10] Subramanyam D, Lamouille S, Judson RL, et al.Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells[J]. Nat Biotechnol, 2011, 29(5):443-448. [11] Hu S, Wilson KD, Ghosh Z, et al.MicroRNA-302 increases reprogramming efficiency via repression of NR2F2[J]. Stem Cells, 2013, 31(2):259-268. [12] Yan GJ, Yu F, Wang B, et al.MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1[J]. Cancer Lett, 2014, 345(1):39-47. |